Skip to main content
SpringerLink
Log in

A potential role for PRDM12 in the pathogenesis of chronic myeloid leukaemia with derivative chromosome 9 deletion

  • Correspondence
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2

References

  1. Huntly BJ, Reid AG, Bench AJ, Campbell LJ, Telford N, Shepherd P et al. Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia. Blood 2001; 98: 1732–1738.

    Article  CAS  Google Scholar 

  2. Kolomietz E, Marrano P, Yee K, Thai B, Braude I, Kolomietz A et al. Quantitative PCR identifies a minimal deleted region of 120 kb extending from the Philadelphia chromosome ABL translocation breakpoint in chronic myeloid leukemia with poor outcome. Leukemia 2003; 17: 1313–1323.

    Article  CAS  Google Scholar 

  3. Steele-Perkins G, Fang W, Yang XH, Van Gele M, Carling T, Gu J et al. Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily. Genes Dev 2001; 15: 2250–2262.

    Article  CAS  Google Scholar 

  4. Vinatzer U, Mannhalter C, Mitterbauer M, Gruener H, Greinix H, Schmidt HH et al. Quantitative comparison of the expression of EVI1 and its presumptive antagonist, MDS1/EVI1, in patients with myeloid leukemia. Genes Chromosomes Cancer 2003; 36: 80–89.

    Article  CAS  Google Scholar 

  5. Gyory I, Fejer G, Ghosh N, Seto E, Wright KL . Identification of a functionally impaired positive regulatory domain I binding factor 1 transcription repressor in myeloma cell lines. J Immunol 2003; 170: 3125–3133.

    Article  Google Scholar 

  6. Yang XH, Huang S . PFM1 (PRDM4), a new member of the PR-domain family, maps to a tumor suppressor locus on human chromosome 12q23–q24.1. Genomics 1999; 61: 319–325.

    Article  CAS  Google Scholar 

  7. Nishikata I, Sasaki H, Iga M, Tateno Y, Imayoshi S, Asoh N et al. A novel EVI1 gene family, MEL1 lacking a PR domain (MEL1S) is mainly expressed in t(1;3)(p36;q21)-positive AML and blocks G-CSF-induced myeloid differentiation. Blood 2003, in press.

  8. He L, Liu J, Collins I, Sanford S, O'Connell B, Benham CJ et al. Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression. EMBO J 2000; 19: 1034–1044.

    Article  CAS  Google Scholar 

  9. Sasaki O, Meguro K, Tohmiya Y, Funato T, Shibahara S, Sasaki T . Altered expression of retinoblastoma protein-interacting zinc finger gene, RIZ, in human leukaemia. Br J Haematol 2002; 119: 940–948.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by a generous grant from The Kay Kendall Leukaemia Fund. We are grateful to the Wellcome Trust Sanger Institute, Cambs, UK for providing chromosome 9 BAC clones.

Author information

Authors and Affiliations

  1. Department of Academic Haematology, Molecular Cytogenetics Laboratory, Royal Free and University College Medical School, University College London, UK

    A G Reid & E P Nacheva

Authors
  1. A G Reid
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E P Nacheva
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reid, A., Nacheva, E. A potential role for PRDM12 in the pathogenesis of chronic myeloid leukaemia with derivative chromosome 9 deletion. Leukemia 18, 178–180 (2004). https://doi.org/10.1038/sj.leu.2403162

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2403162

  • Springer Nature Limited

This article is cited by

Search

Navigation